Haemek Medical Center

The trials here

What the 22 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis5 trials
• Crohn's disease4 trials
• Childhood cancers2 trials
• Colorectal cancer2 trials
• Coronary artery disease2 trials
• Melanoma2 trials
• Type 2 diabetes2 trials
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Heart failure1 trial
• Hidradenitis suppurativa1 trial
• High blood pressure1 trial
• and 6 more

Phase

• Phase 313 trials
• Phase 23 trials
• Phase 2/32 trials
• Phase 41 trial

Status

• Active, not recruiting10 trials
• Completed7 trials
• Recruiting3 trials
• Not yet recruiting2 trials

Lead sponsor

• Janssen Research & Development, LLC4 trials
• Boehringer Ingelheim3 trials
• Abivax S.A.2 trials
• Takeda2 trials
• Agios Pharmaceuticals, Inc.1 trial
• and 10 more

Running trials

• Active, not recruiting

  A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07196748· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Not yet recruiting

  Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor

  NCT06990217· Phase 4· HaEmek Medical Center, Israel· Source

  Contact: Rula Iskander, MD

• Recruiting

  Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT05696626· Phase 3· LeonaBio· Source

  Contact: Gil Bar-Sela

• Active, not recruiting

  First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer

  NCT06398743· Exact Sciences Corporation· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  ABTECT - Maintenance

  NCT05535946· Phase 3· Abivax S.A.· Source

• Active, not recruiting

  A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

  NCT05608291· Phase 3· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

  NCT05668013· Phase 2· Teva Branded Pharmaceutical Products R&D LLC· Source

• Recruiting

  Met Non Small Cell Cancer Registry (MOMENT)

  NCT05376891· EMD Serono Research & Development Institute, Inc.· Source

  Contact: Gil Bar-Sela (principal investigator)

• Active, not recruiting

  A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

  NCT05347095· Phase 3· Janssen-Cilag Ltd.· Source

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

  NCT05031780· Phase 2/3· Agios Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

  NCT04056247· OncoHost Ltd.· Source

• Recruiting

  Colorectal Metastasis Prevention International Trial 2

  NCT03919461· Phase 2· Assaf-Harofeh Medical Center· Source

  Contact: Doron Kopelman, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• High blood pressure1 recruiting
• Metastatic breast cancer1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· Phase 3· Takeda· Source

• Completed

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· Phase 2/3· Boehringer Ingelheim· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

  NCT05507216· Phase 3· Abivax S.A.· Source

• Completed

  Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

  NCT05514548· Phase 2· Inversago Pharma Inc.· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source